Results 41 to 50 of about 14,230 (249)
Frontiers in Microbiology, 2012 Kaposi’s sarcoma-associated herpesvirus (KSHV), a member of the herpesvirus family, has evolved to establish a long-term, latent infection of cells such that while they carry the viral genome gene expression is highly restricted.
Hye-Ra eLee +3 more
doaj +1 more source
The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus
Advances in Virology, 2010 Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiological agent of Kaposi's sarcoma (KS), the most frequently arising malignancy in individuals with untreated HIV/AIDS.
Rebecca C. Robey +2 more
doaj +1 more source
Long Non-Coding RNA and Epigenetic Gene Regulation of KSHV
Viruses, 2014 Kaposi’s sarcoma-associated herpesvirus (KSHV/human herpesvirus 8) is a γ-herpesvirus linked to Kaposi’s sarcoma (KS) and two lymphoproliferative disorders, primary effusion lymphoma (PEL or body-cavity B-lymphoma [BCBL]) and a subset of Multicentric ...
Mel Campbell +2 more
doaj +1 more source
mBio, 2020 Kaposi’s sarcoma-associated herpesvirus (KSHV) has recently been found to generate circular RNAs (circRNAs) from several KSHV genes, most abundantly from K10 (viral interferon regulatory factor 4 [vIRF4]), K7.3, and polyadenylated nuclear (PAN) RNA.
Bizunesh Abere +5 more
doaj +1 more source
Kaposi’s sarcoma in AIDS patients: a case series
Przegląd DermatologicznyKaposi’s sarcoma is a multifocal tumor of endothelial origin associated with human herpesvirus 8 infection. Lesions typically appear as patches, plaques, or hemorrhagic nodules.
Małgorzata Dominiak +3 more
doaj +1 more source
Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections. [PDF]
, 2018 The CRISPR/Cas9 system has been applied in the genome editing and disruption of latent infections for herpesviruses such as the herpes simplex virus, Epstein⁻Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus.
Chen, Yuan-Chuan +3 more
core +2 more sources
Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study. [PDF]
, 2014 HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both the causative agent, Kaposi's sarcoma associated-herpesvirus (KSHV), and the major risk factor, HIV, are prevalent. In a nested case-control study within a
Elliott, Alison M +8 more
core +3 more sources
Virion Proteins of Kaposi's Sarcoma-Associated Herpesvirus [PDF]
Journal of Virology, 2005 ABSTRACT The proteins that compose a herpesvirus virion are thought to contain the functional information required for de novo infection, as well as virion assembly and egress. To investigate functional roles of Kaposi's sarcoma-associated herpesvirus (KSHV) virion proteins in viral productive replication and de novo infection, we attempted ...
Fan Xiu, Zhu +3 more
openaire +2 more sources
JEADV Clinical Practice, EarlyView.ABSTRACT Kaposi sarcoma (KS) is a vascular neoplasm associated with human herpesvirus 8 (HHV‐8), typically affecting immunocompromised individuals. However, emerging reports describe cases in HIV‐negative men who have sex with men (MSM), constituting a proposed non‐epidemic variant.
M. Sin‐Soler +5 more
wiley +1 more source
Viral hijacking of cellular metabolism. [PDF]
, 2019 This review discusses the current state of the viral metabolism field and gaps in knowledge that will be important for future studies to investigate.
Ch'ng, James +2 more
core